SOP Guide for Pharma

BA-BE Studies: SOP for Plasma Separation and Aliquoting – V 2.0

BA-BE Studies: SOP for Plasma Separation and Aliquoting – V 2.0

Standard Operating Procedure for Plasma Separation and Aliquoting in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/074/2025
Supersedes SOP/BA-BE/074/2022
Page No. Page 1 of 10
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the procedure for separation of plasma from whole blood and its subsequent aliquoting into labelled containers for storage and bioanalysis during Bioavailability/Bioequivalence (BA/BE) studies.

2. Scope

This SOP applies to all laboratory personnel involved in the post-centrifugation handling of blood samples for plasma separation and aliquoting at the clinical research facility or designated laboratory site.

3. Responsibilities

4. Accountability

The Bioanalytical Manager is accountable for ensuring plasma separation and aliquoting are conducted in accordance with regulatory requirements and analytical reliability standards.

5. Procedure

5.1 Pre-Separation Checks

  1. Ensure centrifuged tubes are:
    • Intact without hemolysis or leakage
    • Properly labelled
    • Handled using gloves to avoid contamination
  2. Verify each subject ID and time point using the sampling log.

5.2 Plasma Separation

  1. Use sterile disposable pipettes for each sample.
  2. Carefully aspirate the clear plasma layer without disturbing the buffy coat or red cells.
  3. Transfer plasma to pre-labelled cryovials or polypropylene tubes.

5.3 Aliquoting

  1. If multiple aliquots are required:
    • Equally divide the plasma into pre-labelled aliquot tubes (e.g., A1, A2, A3)
    • Label tubes with subject ID, timepoint, aliquot number, and date
  2. Place immediately in cold racks or freezer boxes based on specified storage conditions.

5.4 Sample Volume Documentation

  1. Record the volume of plasma separated and aliquoted in Annexure-1: Plasma Separation Log.
  2. Note any discrepancies (e.g., low volume, hemolysis) and inform QA and the PI.

5.5 Sample Transfer and Storage

  1. Transfer samples to designated storage freezer:
    • -20°C for interim storage
    • -70°C for long-term storage, if specified
  2. Log freezer details and time of storage in Annexure-2: Aliquot Storage Log.

5.6 Deviation Handling

  1. Any cross-contamination, incorrect labelling, or sample damage must be documented in Annexure-3: Sample Handling Deviation Log.

6. Abbreviations

7. Documents

  1. Plasma Separation Log – Annexure-1
  2. Aliquot Storage Log – Annexure-2
  3. Sample Handling Deviation Log – Annexure-3

8. References

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Plasma Separation Log

Subject ID Timepoint Volume (mL) Aliquot Nos. Initials Remarks
VOL-074 2h 4.5 A1, A2 Sunita Reddy

Annexure-2: Aliquot Storage Log

Subject ID Aliquot No. Freezer ID Rack No. Storage Temp Time Handled By
VOL-074 A1 FZ-03 R2 -70°C 09:15 R. Pawar

Annexure-3: Sample Handling Deviation Log

Subject ID Issue Date Reported By Corrective Action Reviewed By
VOL-074X Hemolysis observed 17/04/2025 Nisha Verma Sample discarded, noted in CRF Dr. Arvind Shah

Revision History:

Revision Date Revision No. Details Reason Approved By
12/01/2022 1.0 Initial release Process standardization QA Head
17/04/2025 2.0 Incorporated detailed volume logging and deviation annexure Regulatory alignment QA Head
Exit mobile version